Published in JAMA Neurology · View the paper (DOI)
A recent study found that standard therapy plus catheter ablation did not significantly reduce the risk of primary composite end point in patients with atrial fibrillation and a recent stroke history. The observed event rate was lower than anticipated, suggesting underpowered detection of clinically meaningful differences.
Coverage from 2 institutions